TRECA - TREatment of Colorectal Adenomas and Early Colorectal CAncer in Region Västra Götaland
NCT ID: NCT04788368
Last Updated: 2022-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2021-03-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Locally Advanced Colorectal Cancer and Local Recurrences in Västra Götaland
NCT04406974
Local Recurrence Due to Rectal Cancer in Sweden
NCT04404777
Endoscopic Posterior Mesorectal Resection in T1 Rectal Cancer
NCT00531297
Surgery for Gastrointestinal Metastases of Malignant Melanoma - a Single Center Retrospective Cohort Study
NCT03879395
IPC Status as a Surgical Quality Marker in Rectal Cancer Surgery
NCT02081547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients treated with TEM - transanala microsurgery
Early rectal cancer treated with TEM - full thickness resection
Surgical resection
Surgical resection with either of the above mentioned techniques
Patients treated with ESD
Early rectal cancer treated with the endoscopic treatment ESD - endoscopic submucosal resection
Surgical resection
Surgical resection with either of the above mentioned techniques
Patients treated with EMR
Early rectal cancer treated with the endoscopic treatment EMR - endoscopic mucosal resection
Surgical resection
Surgical resection with either of the above mentioned techniques
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgical resection
Surgical resection with either of the above mentioned techniques
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eva Angenete
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sahlgrenska University Hospital
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TRECA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.